Reconsiderations by the Independent Review Entity

If a Part D plan sponsor issues an unfavorable or partially favorable redetermination decision, the enrollee, the enrollee's representative, or the enrollee's prescriber may appeal the decision to the Independent Review Entity (IRE), also commonly called the Part D Qualified Independent Contractor (QIC), by requesting a reconsideration. C2C Innovative Solutions, Inc. is the current Part D IRE, effective February 1, 2021. Maximus Federal Services is the former Part D IRE.   

PLANS SHOULD NOTE: Case files requested by MAXIMUS should be sent to MAXIMUS and case files requested by C2C should be sent to C2C.

For more information about appointing a representative, see section 20 in the Parts C & D Enrollee Grievances, Organization/Coverage Determinations, and Appeals Guidance, using the link in the "Downloads" section below.

How to Request a Reconsideration

An enrollee, an enrollee's representative, or an enrollee's prescriber may request a standard or expedited reconsideration.

  • The request must be filed with the IRE within 60 calendar days from the date of the plan sponsor's redetermination decision notice.
  • All requests must be made in writing, which includes by fax.
  • An enrollee, an enrollee's representative, or an enrollee's prescriber may use the model "Request for Reconsideration of Medicare Prescription Drug Denial" form to request a reconsideration with the IRE (using the left navigation menu, go to the "Forms" webpage).

If a Medicare prescription drug (Part D) plan enrollee wants to appeal a Part D plan's unfavorable or partially favorable redetermination, the appeal request must be sent to the IRE. 

Maximus Federal Services is no longer the Part D IRE effective January 31, 2021 at 11:59pm EST.

Maximus Federal Services                    
3750 Monroe Avenue
Suite 703
Pittsford, NY  14534-1302

Beginning February 1, 2021 at 12:00am EST, reconsideration appeals requests must be sent to the new IRE, C2C, at one of the following addresses:

Part D QIC Portal Address:

https://www.c2cinc.com//Appellant-Signup

Standard Mail:

C2C Innovative Solutions, Inc. 
Part D Drug Reconsiderations 
P.O. Box 44166
Jacksonville, FL 32231-4166

Courier or Tracked Mail such as FedEx or UPS:

C2C Innovative Solutions, Inc.
Part D QIC
301 W. Bay St., Suite 600
Jacksonville, FL 32202

The IRE’s website has many features that allow enrollees, enrollee representatives, plan sponsors, and physicians or other prescribers to obtain information regarding the Medicare Part D reconsideration process. To access the IRE’s website, use the link in the "Related Links" section below.  Also provided in the "Related Links" section below is a link to the Part D QIC Reconsideration Procedure Manual (click on the "Part D QIC Manual" link).

Note: The Part D QIC Searchable Website Database will also transition to C2C effective February 1, 2021. Currently, all Part D appeals data can be found on Maximus' website at: https://qicappeals.cms.gov/qicportal/#/decisionSearch. Starting on February 1, 2021, Part D appeals data can also be found at the following address: https://PartDAppeals.C2Cinc.com/decisionsearch/.

How the IRE Processes Reconsideration Requests

Once the benefit request is received by the IRE, the IRE must make its decision and provide written notice of its decision as quickly as the enrollee's health requires, but no later than 72 hours for expedited requests or 7 calendar days for standard requests from receipt of the request. This timeframe may be extended for up to 14 calendar days if the case involves an exception request and the IRE has not received the supporting statement from the doctor or other prescriber supporting the request, and/or the proper documentation of representation has not been received. 

For payments, the IRE must make its decision and provide written notice of their decision (and instruct plans to make payment, when appropriate) within 14 calendar days after receiving a request. For expedited reconsiderations, initial notice may be provided verbally, so long as a written follow-up notice is mailed to the enrollee within 3 calendar days of the verbal notification.

If the decision is unfavorable or partially favorable, the decision notice will contain the information needed to file a request for a hearing with an Administrative Law Judge within the Office of Medicare Hearings and Appeals (OMHA). Parties to the hearing may waive their right to the oral hearing and request that a decision be made based on the record. Use the left navigation menu on this page to link to other pages that contain detailed information about hearings with an ALJ and obtaining an on the record review by OMHA, or any other level of appeal.

Fact Sheet: Part D Benefit Reconsideration Appeals Data

These reports summarize and highlight some of the key data on reconsiderations since the inception of the Medicare prescription drug benefit program on January 1, 2006. To view the Fact Sheets, click on the link "Fact Sheets Part D Reconsideration Appeals Data" link in the "Downloads" section below.

Page Last Modified:
02/03/2021 02:18 PM